Controlled Drugs and Substances Act
Schedule I
Source: Canadian Legal Information Institute (CanLII). Controlled Drugs and Substances Act, S.C. 1996, c. 19, as amended
7.
Phenalkoxams, their salts, derivatives and salts of derivatives including:
3D rendering of Dimenoxadol
(1)
Dimenoxadol (Dimethylaminoethyl 1-ethoxy-1,1-diphenylacetate)
UK: MDA Part I Class A Section 1(a) Dimenoxadole
UN: Narcotics Part 1 Section 1 Dimenoxadol
US: CSA Schedule I Section b Subsection 21 Dimenoxadol
⇒
PubChem: 17036; ChemSpider: 16137; Wikipedia: Dimenoxadol
3D rendering of Dioxaphetyl butyrate
(2)
Dioxaphetyl butyrate (Ethyl 2,2-diphenyl-4-morpholinobutyrate)
Effective 22 Apr 1997, SOR/97-230 replacement for:
Dioxaphetylbutyrate (Ethyl 2,2-diphenyl-4-morpholino butyrate)
UK: MDA Part I Class A Section 1(a) Dioxaphetyl butyrate
UN: Narcotics Part 1 Section 1 Dioxaphetyl butyrate
US: CSA Schedule I Section b Subsection 24 Dioxaphetyl butyrate
⇒
PubChem: 48194; ChemSpider: 43838; Wikipedia: Dioxaphetyl butyrate
3D rendering of Dextropropoxyphene
(3)
Dextropropoxyphene ([S-(R*,S*)]-α-[2-(Dimethylamino)-1-methylethyl]-α-phenylbenzeneethanol, propanoate ester)
UK: MDA Part III Class C Section 1(a) Dextropropoxyphene
UN: Narcotics Part 1 Section 2 Dextropropoxyphene and Part 2 Section 3 Dextropropoxyphene
US: CSA Schedule II Section c Subsection 5 Dextropropoxyphene and Schedule IV Section b Subsection 2 Dextropropoxyphene
⇒
PubChem: 10100; ChemSpider: 9696; Wikipedia: Dextropropoxyphene
11 March 2016 · Creative Commons BY-NC-SA ·